Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 21 Feb 2023 for Cullinan Oncology, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Patrick Baeuerle: trading record in brief
Patrick Baeuerle appears in our data through filings on Cullinan Therapeutics, Inc. shares, published by SEC (Form 4). We count 4 filings; the first trade dates from 10 August 2021 and the latest from 17 February 2023.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 21 February 2023, reports a share grant in Cullinan Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Patrick Baeuerle
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
38,500 shares0Common StockSEC:0000899243-23-005731:0
37,500 shares0Common StockSEC:0000899243-22-006419:0
11,000 shares@ US$4.3049.8% of flowCommon StockSEC:0000899243-21-035415:0
11,000 shares@ US$4.3050.2% of flowCommon StockSEC:0000899243-21-034306:0
4 of 4 declarations
